Akumentis Healthcare launches Clasepi, synthetic CBD for epilepsy
Clasepi comes with important usage considerations; it is not recommended for individuals allergic to cannabidiol or any of its…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dravet syndrome
US FDA grants approval of Fintepla to Zogenix
Fintepla offers an additional effective treatment option for the treatment of seizures associated with Dravet syndrome: Zogenix